The price of Vumon (teniposide) can vary significantly based on factors such as dosage, formulation, and the specific healthcare provider or pharmacy dispensing it. As a chemotherapy drug, it is typically administered in a clinical setting.
What is Vumon used for?
Vumon, with the active ingredient teniposide, is a chemotherapy medication. It is primarily used to treat certain types of cancer, including small cell lung cancer, and sometimes in combination with other drugs for acute lymphoblastic leukemia [1].
How is Vumon administered?
Vumon is given intravenously, meaning it is infused into a vein. This is usually done in a hospital or clinic under the supervision of a healthcare professional [1].
Who manufactures Vumon?
Vumon was historically manufactured by Bristol-Myers Squibb [1].
What is the mechanism of action for Vumon?
Teniposide belongs to a class of drugs called podophyllotoxin derivatives. It works by inhibiting topoisomerase II, an enzyme essential for DNA replication, repair, and transcription. By disrupting DNA processing, teniposide leads to DNA strand breaks and cell death, particularly in rapidly dividing cancer cells [1].
When does Vumon's patent protection expire?
Information regarding specific patent expiry dates for Vumon can be found on specialized databases. For instance, DrugPatentWatch.com tracks patent information for various pharmaceuticals, including older drugs and their formulations [2]. Searching such resources would provide precise details on when patent exclusivity for Vumon may have ended or is set to end.
Are there generic versions of Vumon available?
The availability of generic versions of Vumon depends on patent status and regulatory approval. Once patent protection expires and generic manufacturers are able to produce and market the drug, lower-cost generic alternatives may become available [2]. This can influence the overall market price and accessibility.